IQI
PBYI icon

Integrated Quantitative Investments’s Puma Biotechnology PBYI Stock Holding History

Integrated Quantitative Investments’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59,727
Closed -$177K – 423
2025
Q1 		$177K Sell
59,727
-139
-0.2% -$435 0.09% 269
2024
Q4 		$183K Buy
+59,866
New +$174K 0.09% 281

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Integrated Quantitative Investments's PBYI Position: Q2 2025 in Review

Integrated Quantitative Investments sold out of Puma Biotechnology (PBYI) in Q2 2025, closing a stake of 59,727 shares — an estimated $177K sold.

Integrated Quantitative Investments first reported a position in PBYI in Q4 2024 and held it in 2 quarters. The position peaked at $183K in Q4 2024. 121 funds tracked by Wall St. Rank hold PBYI as of Q2 2025.

  • Integrated Quantitative Investments reported no remaining Puma Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Integrated Quantitative Investments sold 59,727 Puma Biotechnology shares in Q2 2025, an estimated $177K.
  • Integrated Quantitative Investments first reported a position in Puma Biotechnology in Q4 2024 and held it in 2 quarters.
  • Integrated Quantitative Investments's Puma Biotechnology position peaked at $183K in Q4 2024.
  • 121 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2025.

Based on Integrated Quantitative Investments's 13F filing for Q2 2025, filed 11 Aug 2025.